TELEhealth Shared Decision-making COaching for Lung Cancer Screening in Primary carE (TELESCOPE)

Status: Recruiting
Location: See all (2) locations...
Intervention Type: Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Hypothesis 1a: The investigators anticipate that navigator decision coaching, compared to enhanced usual care (EUC) will result in higher quality SDM for lung cancer screening (LCS )(primary outcome), greater knowledge of lung cancer screening benefits and harms, and lower decisional conflict. Hypothesis 1b: Compared to enhanced usual care (EUC), we expect that TELESCOPE will result in more screening discussions, increased initial for lung cancer screening (LCS) with low-dose CT scan (LDCT) uptake among interested participants, increased adherence to repeat LCS and diagnostic testing, and increased smoking cessation referrals for current smokers. Hypothesis 2: The investigators expect that a booster coaching session will increase adherence to repeat lung cancer screening (LCS).

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: t
View:

⁃ \- Inclusion Criteria Cluster Randomized Trial

⁃ Eligibility of patients for the cluster randomized trial will follow United States Preventive Services Task Force criteria for lung cancer screening. Specifically, patients must:

• Be 50 to 77 years of age

• Be a current or former smoker having quit within the past 15 years

• Have at least a 20 pack-year smoking history

• Be scheduled for a non-acute care visit at one of the study sites. Interviews (N=50)

⁃ Participants completing the semi-structured interviews will be:

• A practicing primary care clinician or a clinic director (n=20), nursing director, or clinic practice administrator (n=20) at one of the participating sites or a TELESCOPE study patient navigator (n=7) and nurse navigator (n = 3)

• Age 18 or older

• Fluent in English Online surveys (N=130)

⁃ Providers completing online PRISM construct surveys will be:

• A practicing primary care provider at one of the participating sites or a TELESCOPE study navigator

• Age 18 or older

• Fluent in English

Locations
United States
New Jersey
Rutgers Cancer Institute
RECRUITING
New Brunswick
Texas
The University of Texas MD Anderson Cancer Center
ACTIVE_NOT_RECRUITING
Houston
Contact Information
Primary
Julie E Chapman-Greene, PhD, MPH
chapmaje@cinj.rutgers.edu
732-865-3375
Backup
Rebecca Ayala
raa191@cinj.rutgers.edu
732-258-6982
Time Frame
Start Date: 2023-02-14
Estimated Completion Date: 2027-10-31
Participants
Target number of participants: 594
Treatments
Experimental: TELESCOPE intervention
Participants will be surveyed at baseline and at one-week after the scheduled primary care office visit. If a participant is a current smoker then they are offered and navigated to evidence-based smoking cessation. If the participant is interested in screening, an LDCT is ordered. Support for screening, diagnostic testing and oncology care will be provided as needed from the Nurse Navigators.
No_intervention: Enhanced usual care (EUC)
Participants will be surveyed at baseline and at one-week after the scheduled primary care office visit. Primary and secondary outcome data related to the office visit will be collected.
Related Therapeutic Areas
Sponsors
Leads: Rutgers, The State University of New Jersey
Collaborators: National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI)

This content was sourced from clinicaltrials.gov